Tags

Type your tag names separated by a space and hit enter

Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication.
Vaccine. 2016 Mar 04; 34(10):1247-51.V

Abstract

BACKGROUND

The 17D-yellow fever (YF) vaccination is considered contraindicated in immune-compromised patients; however, accidental vaccination occurs. In this population, measuring the immune response is useful in clinical practice.

METHODS

In this study we compare two antibody tests (the Immune Fluorescence Assay and the Plaque Reduction Neutralization Test) in a group of Dutch immune-compromised travellers with a median of 33 days (IQR [28-49]) after primary YF vaccination.

RESULTS

We collected samples of 15 immune-compromised vaccinees vaccinated with the 17D yellow fever vaccine between 2004 and 2012. All samples measured in the plaque reduction neutralization test yielded positive results (>80% virus neutralization with a 1:10 serum dilution). Immune Fluorescence Assay sensitivity was 28% (95% CI [0.12-0.49]). No adverse events were reported.

CONCLUSIONS

All immune-compromised patients mounted an adequate response with protective levels of virus neutralizing antibodies to the 17-D YF vaccine. No adverse effects were reported. Compared to the plaque reduction neutralization test, the sensitivity of the Immune Fluorescence Assay test was low. Further research is needed to ascertain that 17D vaccination in immune-compromised patients is safe.

Authors+Show Affiliations

Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: a.goorhuis@amc.uva.nl.Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.Department for Immune Mechanisms (IMM), Centre for Immunology od Infectious Diseases and Vaccines (IIV), National Institute for Public Health and the Environment (RIVM), Utrecht, The Netherlands.Department of Virology, Academic Medical Center, Amsterdam, The Netherlands.Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

26845742

Citation

Wieten, Rosanne W., et al. "Comparison of the PRNT and an Immune Fluorescence Assay in Yellow Fever Vaccinees Receiving Immunosuppressive Medication." Vaccine, vol. 34, no. 10, 2016, pp. 1247-51.
Wieten RW, Jonker EF, Pieren DK, et al. Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication. Vaccine. 2016;34(10):1247-51.
Wieten, R. W., Jonker, E. F., Pieren, D. K., Hodiamont, C. J., van Thiel, P. P., van Gorp, E. C., de Visser, A. W., Grobusch, M. P., Visser, L. G., & Goorhuis, A. (2016). Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication. Vaccine, 34(10), 1247-51. https://doi.org/10.1016/j.vaccine.2016.01.037
Wieten RW, et al. Comparison of the PRNT and an Immune Fluorescence Assay in Yellow Fever Vaccinees Receiving Immunosuppressive Medication. Vaccine. 2016 Mar 4;34(10):1247-51. PubMed PMID: 26845742.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication. AU - Wieten,Rosanne W, AU - Jonker,Emile F F, AU - Pieren,Daan K J, AU - Hodiamont,Caspar J, AU - van Thiel,Pieter P A M, AU - van Gorp,Eric C M, AU - de Visser,Adriëtte W, AU - Grobusch,Martin P, AU - Visser,Leo G, AU - Goorhuis,Abraham, Y1 - 2016/02/01/ PY - 2015/08/17/received PY - 2016/01/08/revised PY - 2016/01/18/accepted PY - 2016/2/5/entrez PY - 2016/2/5/pubmed PY - 2016/9/24/medline KW - Immune-compromised KW - Indirect Fluorescence Assay (IFA) KW - Plaque Reduction Neutralization Test (PRNT) KW - Vaccination KW - Yellow fever SP - 1247 EP - 51 JF - Vaccine JO - Vaccine VL - 34 IS - 10 N2 - BACKGROUND: The 17D-yellow fever (YF) vaccination is considered contraindicated in immune-compromised patients; however, accidental vaccination occurs. In this population, measuring the immune response is useful in clinical practice. METHODS: In this study we compare two antibody tests (the Immune Fluorescence Assay and the Plaque Reduction Neutralization Test) in a group of Dutch immune-compromised travellers with a median of 33 days (IQR [28-49]) after primary YF vaccination. RESULTS: We collected samples of 15 immune-compromised vaccinees vaccinated with the 17D yellow fever vaccine between 2004 and 2012. All samples measured in the plaque reduction neutralization test yielded positive results (>80% virus neutralization with a 1:10 serum dilution). Immune Fluorescence Assay sensitivity was 28% (95% CI [0.12-0.49]). No adverse events were reported. CONCLUSIONS: All immune-compromised patients mounted an adequate response with protective levels of virus neutralizing antibodies to the 17-D YF vaccine. No adverse effects were reported. Compared to the plaque reduction neutralization test, the sensitivity of the Immune Fluorescence Assay test was low. Further research is needed to ascertain that 17D vaccination in immune-compromised patients is safe. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/26845742/Comparison_of_the_PRNT_and_an_immune_fluorescence_assay_in_yellow_fever_vaccinees_receiving_immunosuppressive_medication_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(16)00081-5 DB - PRIME DP - Unbound Medicine ER -